Trachoma, a contagious keratoconjunctivitis(KC), caused by Chlamydia trachomatis infection, is rife in 57 countries in the world at present. The World Health Organization(WHO)listed the global alliance to eliminate blinding trachoma by 2020 as one of top priorities of its blindness prevention in 1998. A simplified classification system for identifying and naming trachoma, designated by WHO, and the SAFE strategy based on community intervention were extended continuously in the world in 10 years since then. The trachoma prevalence trend has showed a change compared with that in the past. China has launched the blindness prevention action, aimed to eliminate blinding trachoma by 2016. In this paper,we reviews progress in diagnosis, treatment and epidemic of trachoma since the extension of the SAFE strategy.